| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.048 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |